Rotem Industries - Medical Imaging
Li-Or Chemke is an accomplished professional with extensive experience in sales, marketing, and business development across various industries. Currently serving as a Board Member and Sales and Marketing VP at Rotem Industries since April 2021, Li-Or Chemke contributes to a Hi-tech company focused on commercializing technologies globally. Prior roles include VP of International Business at China Security Co., Ltd. and senior management positions at Avery Dennison Graphics Solutions and Hanita Coatings Israel, where responsibilities included managing business units and driving international sales initiatives. Li-Or Chemke holds an MBA in Marketing from the University of Haifa, a B.Sc. in Engineering/Industrial Management from Ben-Gurion University of the Negev, and has completed executive education at Tel-Aviv University.
This person is not in the org chart
This person is not in any teams
Rotem Industries - Medical Imaging
Hi-tech company specializing in the development and commercialization of technologies from research centers and start-ups. Rotem markets its products worldwide and has subsidiaries in the USA and Germany. Main business areas are medical imaging, crystal manufacturing, radiation detection and renewable energy. Rotem Industries' Medical Imaging business is a world leader in consumables for PET imaging. Rotem develops, manufactures and supplies complete packages for the production of radiotracers: oxygen-18 enriched water, plastic cassettes, precursors and complete reagent kits for a range of synthesis modules. Rotem serves its customers through a global distribution network, and Rotem excels in uncompromising product quality coupled with a deep understanding of customer needs to ensure uniformly high production yields and unsurpassed quality. The passion for quality is driven by a team of highly skilled and dedicated professionals who recognize the critical role their products play in the PET radiotracer production chain. Rotem is very active in the development and production of consumables for new radiotracers under development. These projects benefit from our interdisciplinary expertise and direct market access, which is the result of years of direct, day-to-day, close collaboration with radiopharmaceutical companies worldwide.